We’re learning more about the super-effective “triple-G” weight loss drug retatrutide. The drug, the first of its kind to ...
Eli Lilly's triple G agonist retatrutide has achieved impressive weight loss in patients with type 2 diabetes and obesity, ...
Hosted on MSN
What to know about new 'triple-G' drug that's helped patients lose a quarter of their body weight
The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight loss. Known as “triple-G,” injectable retatrutide levies a triple whammy on the GLP-1, GIP and ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Eli Lilly's triple-G agonist candidate, retatrutide, led to significant reductions in both blood sugar levels and body weight in its first phase 3 diabetes trial, suggesting a potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results